Everest Medicines has announced groundbreaking results from its Phase 1b/2a clinical trial of EVER001, a novel Bruton’s tyrosine kinase...
Lire la suiteBranston, one of the UK’s leading potato suppliers, is gearing up to launch an exciting new brand, Nanna Tate,...
Lire la suiteTeva Pharmaceutical Industries has unveiled encouraging results from its Phase 3 SPACE study, highlighting the efficacy and safety of...
Lire la suiteVirtue Drinks, a pioneering clean-label beverage company, has successfully closed a £2m funding round as it gears up to...
Lire la suiteA groundbreaking new treatment for asthma and chronic obstructive pulmonary disease (COPD) could revolutionise how these life-threatening conditions are...
Lire la suiteIn a significant milestone for autoimmune disease research, argenx’s investigational therapy, subcutaneous efgartigimod alfa, has been granted Promising Innovative...
Lire la suite